Discussion about this post

User's avatar
Fenbendazole & Cancer's avatar

Salicylic Acid Cocrystal

Fenbendazole-salicylic acid is a laboratory-created crystal mixture (cocrystal) designed to help the poorly soluble veterinary drug fenbendazole dissolve faster and more completely.

Separately, salicylic acid is the base compound. When you take aspirin, your body breaks it down into salicylic acid as its main active metabolite.

Salicylic acid would also be an excellent vehicle to improve the drug release rate of fenbendazole. Fenbendazole-salicylic acid performed exceptionally well, achieving a 100% drug release rate in under 1 hour and a solubility of 1.052 mg/ml. This improved drug-release rate could enable immediate therapeutic action.

Aspirin was introduced into clinical practice more than 100 years ago. This unique drug belongs to a family of compounds called the salicylates, the simplest of which is salicylic acid, the principal metabolite of aspirin. Salicylic acid is responsible for aspirin's anti-inflammatory action. Yet salicylic acid and other salicylates occur naturally in fruits and plants,

*Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer*

QJM 2001 Aug;94(8):445-8.  doi: 10.1093/qjmed/94.8.445.

https://pubmed.ncbi.nlm.nih.gov/11493722/

Steve Colletti's avatar

Does the poor bioavailability apply to Mebendazole as well as Fenbendazole? and do the same organic acid coformers work the same way with Mebendazole?

Thank you!

2 more comments...

No posts

Ready for more?